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Abstract
Background: The chromothripsis is a biological phenomenon, first observed in tumors and then rapidly described
in congenital disorders. The principle of the chromothripsis process is the occurrence of a local shattering to pieces
and rebuilding of chromosomes in a random order. Congenital chromothripsis rearrangements often involve
reciprocal rearrangements on multiple chromosomes and have been described as cause of contiguous gene
syndromes. We hypothesize that chromothripsis could be responsible for known 9q21.13 microdeletion syndrome,
causing a composite phenotype with additional features.
Case presentation: The case reported is a 16- years-old female with a complex genomic rearrangement of
chromosome 9 including the critical region of 9q21.13 microdeletion syndrome. The patient presents with platelet
disorder and thyroid dysfunction in addition to the classical neurobehavioral phenotype of the syndrome.
Conclusions: The presence of multiple rearrangements on the same chromosome 9 and the rebuilding of chromosome
in a random order suggested that the rearrangement could origin from an event of chromthripsis. To our knowledge
this is the first report of congenital chromothripsis involving chromosome 9. Furthermore this is the only case of 9q21.13
microdeletion syndrome due to chromothripsis.
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Background
The chromothripsis is a newly recognized biological
phenomenon, first observed in tumours [1] and then
rapidly described in congenital disorders [2, 3]. The
principle of the chromothripsis process is the occur-
rence of a local shattering to pieces of chromosomes in
an unique catastrophic cellular event, followed by a re-
assembly of the pieces into one or more chaotic deriva-
tive chromosomes by DNA repair processes, most
likely non-homologous end joining [4]. Some pieces
may be lost or combined in small circular extra-
chromosomes (double-minute chromosomes).
The chromothripsis rearrangements found in cancer are
characterised by high copy number changes [1]; in
contrast, a striking characteristic of congenital chromo-
thripsis rearrangements is their relatively balanced state,
despite the presence of multiple DNA breaks across sev-
eral chromosomes [5, 6]. This does not mean that unbal-
anced chromothripsis does not occur in germline or
during post-zygotic divisions, but it strongly emphasizes
the effect of selection as a bias factor in the assessment of
congenital chromothripsis, since only balanced chromo-
thripsis outcomes compatible with life have been found in
individuals to date.
Next-generation sequencing and FISH experiments have
been performed to characterise congenital chromothripsis-
associated complex chromosomal rearrangements involving
chromosomes 1, 2, 3, 5, 7, 8, 13, 15,19, X [5–8]. Chromo-
thripsis events have been described as cause of contiguous
gene syndromes such as Cri-du-chat syndrome [9] and
16q21-q22.1 deletion [3] and in disruption of the FOXP2
(forkhead box P2) gene [7].
* Correspondence: rgenesio@unina.it
†Equal contributors
1Department of Molecular Medicine and Medical Biotechnology, Federico II
University, Naples, Italy
Full list of author information is available at the end of the article
© 2015 Genesio et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Genesio et al. Molecular Cytogenetics  (2015) 8:96 
DOI 10.1186/s13039-015-0199-3
To our knowledge, congenital chromothripsis involv-
ing chromosome 9 has not yet been reported, as well as
chromothripsis events have never been associated to the
9q21.13 microdeletion syndrome.
Here, we report a case of a girl with severe intellectual
disability, epilepsy, platelet dysfunction, dysmorphisms
and hypothyroidism, carrying a complex chromosomal re-
arrangement, which involves the critical region of the
9q21.13 microdeletion syndrome. Although many pheno-
typic signs may be ascribed to this syndrome, the proband
presents also with other features, suggesting that the spe-
cific phenotype might be the result of the very complex
rearrangement caused by chromothripsis. We here de-
scribe the molecular characterisation of the rearrange-
ment, analysing possible role of the genes included in it
and speculating about a genotype–phenotype correlation.
Case presentation
Clinical report
We report the case of a 16-years-old female patient. She
was born at term by vaginal delivery. At birth she weighted
2.780 Kg (10° - 25° ct), her length was 48 cm (25°-50°) and
her head circumference 31.7 cm (<3°ct); she had an
APGAR score of 8 at 1’ and 9 at 5’. At the age of 6 months
she showed developmental delay, moderate hypertonia of
limbs and motor development impairment. When she was
7 years old, an impaired platelet aggregation was detected.
At the age of 10 years she had seizures with revulsion of
the eyeballs, hypertonia, enuresis, post-critical sleep and
vomit and received a diagnosis of “secondarily generalized
partial epilepsy”. We examined the proband at the age of
16 years, when dysmorphic features were visibly evident
(Fig. 1), including downslanted palpebral fissures, long eye-
lashes, high palate, pronounced columella, retrognatia and
clinodattily of the 5th finger, irregular shaped CLS on the
left flank; the patient also had malformed, hypoplastic
inner labia, visible only on the superior tract. X-ray exam-
ination demonstrated a flattening of the physiological
cervical and lumbar lordosis and of the dorsal kyphosis. A
diagnosis of subclinic hypothyroidism was performed on
the basis of thyroid hormone profile (FT3: 2,8 pg/ml; FT4:
0,9 ng/dl; TSH: 9,2 μU/ml) and thyroid ultrasound showed
the presence of an iso-hypo echogenic nodule with max-
imal diameters of 10 and 9 mm, with no neoplastic nature,
as shown at the cytological examination. The last I.Q.
evaluation, performed at the age of 16 by the WAIS-R
scale, attested a moderate cognitive impairment (total I.Q
46, Verbal I.Q < 46, Performance I.Q 46).
Methods
Cytogenetic analysis was performed on GTG-banded
metaphases from lymphocytes at a resolution of 500
bands approximately according to the standard cytogen-
etic protocol. The description of karyotypes was made in
accordance with the ISCN 2013 (International System of
Human Cytogenetic Nomenclature).
FISH analysis using Satellite Enumeration Probes (Krea-
tech Diagnostics, Amsterdam, NL) and bacterial artificial
chromosome probes (BAC) were done according to stand-
ard procedures. The BAC probes were selected from the
UCSC genome browser [10] and provided by Professor M.
Rocchi (rocchi@biologia.uniba.it). Multicolour banding
(MCB) was performed using the multicolour banding
DNA Probe Kit based on microdissection derived region-
specific libraries for chromosome 9 (Meta-Systems, Arese
MI). Fluorescent images were analysed using a fluores-
cence microscope (AxioImager.Z1 mot, Zeiss) with ISIS
software imaging system (MetaSystems, Altlussheim,
Germany) for image capturing and processing. A Nim-
bleGen CGX-6 PKI Array chip with a resolution of 175 kb
in the backbone and 50 kb in the targeted region (Roche
NimbleGen, Inc.,Madison,WI, USA) was used in accord-
ance with manufacturer’s guidelines for the whole genome
CGH analysis. The arrays were analyzed using Genogly-
phix® software 3.0 (PerkinElmer Spokane, WA), referring
Fig. 1 Facial phenotype of the patient at the age of 16
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to Hg19 Genome Assembly (GRCh37/hg19). Copy num-
ber variations were classified according to the Database of
Genomic Variants [11], the DECIPHER Database [12] and
the UCSC Genome Browser [10].
Results
Cytogenetic analysis revealed an abnormal female karyo-
type with 46 chromosomes and a chromosomal re-
arrangement involving one chromosome 9 (der(9)) in all
the examined cells. Parental karyotypes were normal.
The array analysis identified a 9q21.11 deletion, span-
ning approximately 176.56 kb and a 9q21.12q21.2 dele-
tion, spanning approximately 7.44 Mb (Fig. 2). The
derivative chromosome 9 characterised by Multicolour
banding (MCB) showed an anomalous assembly of the
bands from the 9p21 band to 9q31 band (Fig. 3), even
though MCB 9 was not able to identify the 9p13 region
on der(9) perhaps because of a fluorescence overlapping.
Therefore the der(9) was further characterised by dual-
colour-FISH using both the Satellite Enumeration probe
for chromosomes 9 (SE 9) and the BAC probe RP11-
182N22 mapping to 9p13.3 region. This FISH showed
an inversion not revealed by MCB (Fig. 4), as the BAC
probe signal was present in the q arm, instead of the p
arm, of one chromosome 9.
The complete chromosomal characterisation according
to ISCN 2013 was as follows:
46,XX,inv(9)(p13q21.1).ish inv(9)(9pter- > p21::q13- >




The term chromothripsis was introduced to indicate
catastrophic DNA rearrangements in cancer genomes
[1]. More recently, a very similar chromosome shatter-
ing process has been described in constitutional rear-
rangements [5–7].
Congenital chromothripsis rearrangements often involve
reciprocal rearrangements on multiple chromosomes. Fur-
thermore the number of breakpoints for chromothripsis
rearrangements in the germline is substantially lower than
t that observed in cancer [5].
Recently, whole-genome sequencing and FISH analysis
led to the discovery of two other classes of complex cata-
strophic chromosomal rearrangements; namely chromoa-
nasynthesis and chromoplexy [13, 14]. Although the
underlying mechanisms for these phenomena are un-
known and likely different, all of these patterns of rear-
rangements appear to have originated from a single
catastrophic event. Chromoanasynthesis, as well as chro-
mothripsis, affects limited portions of the genome (often a
single chromosome or chromosome arm) and is charac-
terised by a copy number profile alternating loss and gain
of DNA tracts. In contrast to chromothripsis, chromoa-
nasynthesis reflects resynthesis of segments from one
chromatid. Chromoanasynthesis also contains frequent
insertions of short sequences between the rearrange-
ment junctions that are copied from the rearranged
Fig. 2 Array-CGH analysis showing a 9q21.11 deletion, spanning approximately 176.56 kb and a 9q21.12q21.2 deletion, spanning approximately
7.44 Mb
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segments (templated insertions). Chromoplexy is char-
acterised by a closed chain of translocations, with little
or no copy number alteration.
The patient that we have described shows two deletions
and a random and anomalous assembly of the chromo-
some bands on a single chromosome 9 (Fig. 3). Further-
more the two deleted traits have clustered breakpoints
within 9q21 region interrupted by a small region without
DNA gain or loss. These features led us to hypothesize
that this rearrangement could be caused by congenital
chromothripsis.
It is interesting to note that all the cases of congenital
chromothripsis described so far present a composite
phenotype, including known syndromes, due to the com-
plex genomic rearrangements resulting from the cata-
strophic events [3, 7, 9].
The patient here described presents with severe intel-
lectual disability, epilepsy, dysregulation of platelet ag-
gregation, dysmorphisms, genitalia malformations and
hypothyroidism. The array-CGH analysis demonstrated
a 756 kb deletion at 9q21.11 together with a 7.4 Mb de-
letion at 9q21.12-q21.2, which encompasses 20 OMIM
genes and includes the candidate critical region for the
9q21.13 microdeletion syndrome.
The 9q21.13 microdeletion syndrome is a recently dis-
covered condition, characterised by intellectual disability,
seizures and several aspecific dysmorphic features. A
750 kb putative critical region has been proposed [15],
encompassing four genes, RORB, TRPM6, NMRK1 and
OSTF1. RORB (RAR-related orphan receptor B) gene is
Fig. 3 G-Banding image of rearranged chromosomes 9 (on the left) and of the normal chromosome 9 (on the right) and Multicolour banding
image of the rearranged chromosome 9 (on the left) compared to the normal chromosome 9 (on the right) shows bands involved in the rearrangement
Fig. 4 Dual-colour-FISH with centromeric probe (green) for
chromosomes 9 and BAC probe RP11-182N22 (red) mapping in
9p13.3 region showed that the BAC probe signal was present in the
q arm of the der9 (yellow arrow), instead of the p arm of chromosome
9 (blue arrow)
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a strong candidate for neurological disorders [15], there-
fore its haploinsufficiency could be responsible for the
severe neurological impairment observed in our patient.
Even though phenotypic signs of the proband, such as
intellectual disability and epilepsy, may be mostly ascribed
to 9q21.13 microdeletion syndrome, other signs, such as
platelet disorder and hypotiroidism have not been de-
scribed in 9q21.13 syndrome, demonstrating that a wider
size of the deletion, if compared to the critical region for
the 9q21.13 deletion syndrome, the different positioning
of the genes included in the region, due to chromotripsis
events could influence the severity of phenotypic traits of
patient [16, 17].
Both platelet disorder and hypotiroidism might be to as-
cribed to another deleted gene, namely GNAQ, which
maps to 9q21.2, outside the critical region of the 9q21.13
deletion syndrome. GNAQ encodes a guanine nucleotide
binding protein, which is an alpha subunit in the Gq class.
This protein is coupled with 7-transmembrane domain re-
ceptors with a GTPase intrinsic activity that mediates the
induction of phospholipase C-beta into the cells [18]. In
platelets, this signaling is responsible for the calcium
mobilization from the endoplasmic reticulum, that medi-
ates several pathways ending with platelet aggregation,
through the phases of shape change, improvement of the
secretion of activators from the granules and conversion
of GP IIb/IIIa to its activated form [19]. In the first de-
scription of a human platelet G protein defect [20], simi-
larly to our case, the patient had diminished platelet
aggregation and secretion in response to multiple agonists,
despite the presence of normal dense granule stores.
The same gene could be involved in the thyroid dys-
function. Mice lacking the alpha subunits of Gq and
G11 specifically in thyroid epithelial cells showed a se-
vere reduction of the iodine organification and the secre-
tion of thyroid hormone in response to TSH, and the
majority of them developed hypothyroidism within
months after birth [21].
Conclusions
In conclusion, the patient that we have described, with
four rearrangements on a chromosome 9 is the first
case, described so far, in which congenital chromothrip-
sis affects just one chromosome, as well as in cancer.
This is also the first report of congenital chromothrip-
sis involving chromosome 9 and, to our knowledge, this
is the only case of 9q21.13 microdeletion syndrome due
to chromothripsis.
We speculate that chromothripsis could be the basis of
known contiguous gene syndromes, with additional fea-
tures, causing composite phenotypes. We suggest that the
patient’s specific phenotype might be the result of the very
complex rearrangement, caused by chromothripsis. The
different size of the deletion, if compared with the critical
region for the 9q21.13 deletion syndrome, the type and
the positioning of the genes involved in the rearrangement
might influence the severity of the proband’s phenotype.
Going forward, we will better define the features and ori-
gins of this complex chromosome rearrangement by
Whole Genome Sequencing.
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